PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: biology

EMPIRIC TREATMENT OF FEBRILE NEUTROPENIA

EMPIRIC TREATMENT OF FEBRILE NEUTROPENIA Disclaimer Both the format and content of the guidelines will change as they are reviewed and revised on a periodic basis. Any physician using these guidelines to provide TREATMENT for patients will be solely responsible for verifying the doses, providing the prescriptions, and administering the medications described in the guidelines, according to acceptable standards of care. Additional notes: Empirical ANTIFUNGAL therapy should be considered in patients , who are ex

1. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52(4):e56-e93. 2.

Fullscreen Download

Tags:

  Patients, Antimicrobial, Agent, Neutropenic, Antimicrobial agents in neutropenic patients

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of EMPIRIC TREATMENT OF FEBRILE NEUTROPENIA

Documents from same domain

Oncology Nutrition High Protein High Energy …

www.bccancer.bc.ca

High Protein High Energy Food Choices 3 Examples of High Protein Foods • All meat (eg. beef, pork, goat, lamb) • Fish and shellfish • All poultry (eg. chicken, turkey, duck)

  High, Food, Energy, Nutrition, Oncology, Protein, Oncology nutrition high protein high energy, Protein foods

BC CANCER HAZARDOUS DRUG LIST

www.bccancer.bc.ca

BC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of:

  Lists, Hazardous

Safe Handling of Hazardous Drugs - BC Cancer

www.bccancer.bc.ca

A.1 Potential Hazards of Handling Hazardous Drugs..... 1 A.2 Hazardous Drug List.....

  Drug, Lists, Hazardous, Hazardous drugs

“Magic” mouthwash explained - BC Cancer

www.bccancer.bc.ca

FAMILY PRACTICE ONCOLOGY NETWORK JOURNAL / FALL 2014 3 “Magic” mouthwash explained By Dr. Allan Hovan, Provincial Professional Practice Leader,

  Magic, Explained, Mouthwash, Magic mouthwash explained

Symptom Management Guidelines: ORAL …

www.bccancer.bc.ca

Symptom Management Guidelines: ORAL MUCOSITIS . Definition Oral Mucositis (Stomatitis): An acute inflammation and/or ulceration of the …

  Guidelines, Management, Symptom, Oral, Symptom management guidelines, Oral mucositis, Mucositis

Guidelines for Management of CID - BC Cancer

www.bccancer.bc.ca

Disclaimer Both the format and content of the guidelines will change as they are reviewed and revised on a periodic basis. Any physician using these guidelines to provide

  Guidelines, Management, Guidelines for management of cid

British Columbia Cancer Agency POLICY

www.bccancer.bc.ca

British Columbia Cancer Agency ¦ POLICY Title: PREVENTION AND MANAGEMENT OF EXTRAVASATION OF CHEMOTHERAPY Number: III-20 Effective Date: Provincial Systemic Program September 1,1997

  Policy, Management, Prevention, Agency, Columbia, British, Cancer, British columbia cancer agency policy, British columbia cancer agency, 166 policy

Symptom Management Guidelines: FEVER AND …

www.bccancer.bc.ca

Symptom Management Guidelines: FEVER AND NEUTROPENIA . Definition • Fever: A single oral temperature of ≥ 38.3° C (101° F) OR a temperature ≥ 38 ° C (100.4 ° F) which lasts more than 1h

  Guidelines, Management, Fever, Symptom, Oral, Symptom management guidelines, Fever and, Fever and neutropenia, Neutropenia

Symptom Management Guidelines: XEROSTOMIA

www.bccancer.bc.ca

Symptom Management Guidelines: XEROSTOMIA. Definition(s) • Xerostomia: abnormal dryness in the mouth characterized by a marked decrease and/or thickening of saliva, may be

  Guidelines, Management, Symptom, Symptom management guidelines, Xerostomia

Linking the BC Psychosocial Community Oncology …

www.bccancer.bc.ca

Carolyn Jacob - New Regional Professional Practice Leader at the Centre for the North. We welcome Carolyn Jacob, MSW, RSW to her new role at the BC

  Psychosocial, Community, Linking, Oncology, Linking the bc psychosocial community oncology

Related documents

2章 FN に対 治療 - JCQHC

minds4.jcqhc.or.jp

a） Freifeld AG, Bow EJ, Sepkowitz KA, et al：Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer：2010 update by The Infectious Diseases Society of America. Clin Infect Dis 2011；52：e56–e93 参考文献 1） van der Lelie H, Leverstein-Van Hall M, Mertens M, et al：Corynebacterium CDC ...

  Patients, Antimicrobial, Agent, Neutropenic, Antimicrobial agents in neutropenic patients

Medication Administration: Extended-Infusion Piperacillin ...

med.stanford.edu

abstracts of the 42nd interscience conference on antimicrobial agents and chemotherapy. 2002. 9. Ariano RE, Nyhlen A, Donnelly JP, Sitar DS, Harding GK, Zelenitsky SA. Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia. The Annals of pharmacotherapy. Jan 2005;39(1):32-38. 10.

  Patients, Antimicrobial, Agent, Neutropenic, Antimicrobial agents, Neutropenic patients

Staphylococcus aureus Bloodstream Infection Treatment ...

www.unmc.edu

6. Not immunosuppressed or neutropenic 7. Removal of any indwelling catheter ii. It is unknown if transition to oral therapy is safe but in patients with low risk conditions (UTI or skin/soft tissue infection without residual abscess) who meet criteria for uncomplicated BSI transition to active oral agents with good oral

  Patients, Agent, Neutropenic

NCCN Clinical Practice Guidelines in Oncology (NCCN ...

oralcancerfoundation.org

For MDS (neutropenic), AML (neutropenic), and Significant GVHD, "Micafungin (category 2B)" was added. For Allogeneic HCT (neutropenic), Itraconazole (category 2B) was removed. Footnote "k" revised: "Consider antifungal prophylaxis in all patients with GVHD receiving immunosuppressive therapy (IST)"

  Guidelines, Patients, Neutropenic

Clinical Practice Guidelines for the Diagnosis and ...

www.unmc.edu

neutropenic patients, severely ill patients with sepsis, or patients known to be colonized with such pathogens, until the culture and susceptibility data are available and de-escalation of the antibiotic regimen can be done (A-II). 27. In addition to coverage for gram-positivepathogens,em-pirical therapy for suspected CRBSI involving femoral ...

  Patients, Neutropenic, Neutropenic patients

Clinical Practice Guideline for Sepsis Treatment ...

www.mahealthcare.com

broaden antimicrobial activity.) Combination therapy for the routine treatment of Neutropenic Sepsis/Bacteremia. (This does not preclude the use of multidrug therapy to broaden antimicrobial activity.) 4) Administer bolus: 30 ml/kg Crystalloid for hypotension or a …

  Antimicrobial, Neutropenic

Methicillin-Resistant Staphylococcus Aureus (MRSA)

www.ndhealth.gov

2. Empiric treatment for febrile neutropenic patients unless a gram-positive infection is suspected and the institution has a high rate of MRSA. 3. Treatment of one positive blood culture for coagulase-negative staphylococcus if other blood cultures drawn at the same time are negative (i.e., likely contamination). 4.

  Patients, Neutropenic, Neutropenic patients

n GUIDELINES FOR TREATMENT OF CLOSTRIDIUM …

www.med.umich.edu

In patients who do not have the entire colon in place (i.e., a colorectal stump due to Hartman [s procedure), a smaller volume of enema (100 mL) is acceptable. 6. Avoid multiple or prolonged courses of metronidazole in recurrent disease due to the risk for cumulative neurotoxicity. 7. Alternative and/or adjunctive agents: a.

  Guidelines, Patients, Treatment, Clostridium, Agent, Guidelines for treatment of clostridium

Methicillin-Resistant Staphylococcus Aureus (MRSA)

www.ndhealth.gov

2. Empiric treatment for febrile neutropenic patients unless a gram-positive infection is suspected and the institution has a high rate of MRSA. 3. Treatment of one positive blood culture for coagulase-negative staphylococcus if other blood cultures drawn at the same time are negative (i.e., likely contamination). 4.

  Patients, Neutropenic, Neutropenic patients

Symptom Management Guidelines: FEVER and NEUTROPENIA

www.bccancer.bc.ca

Antibiotic prophylaxis may be considered in patients with expected duration of neutropenia (ANC <1.0 X 109/L )) for > 7 days or for patients receiving immunosuppressive regimens (e.g. systemic corticosteroids). Antifungal prophylaxis may be recommended for high risk patients (e.g. those with acute leukemia and stem cell transplantation).

  Patients

Related search queries

Antimicrobial agents in neutropenic patients, Antimicrobial agents, Neutropenic patients, Neutropenic, Patients, Agents, Guidelines, Antimicrobial, GUIDELINES FOR TREATMENT OF CLOSTRIDIUM